From: Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer
Case Subjects No. | (%) | Case Subjects No. | (%) | ||
---|---|---|---|---|---|
Variables | Variables | ||||
Age at study | Gleason Score | ||||
<60 | 51 | <4 | 15 | 5 | |
60–69 | 140 | 4–6 | 122 | 41.2 | |
70–79 | 89 | 7–8 | 133 | 45 | |
>80 | 16 | 9–10 | 26 | 8.8 | |
T Stage | Differential Grade | ||||
T1 | 25 | 8.5 | 1 | 25 | 8.5 |
T2 | 112 | 37.8 | 2 | 245 | 82.7 |
T3 | 111 | 37.5 | 3 | 26 | 8.8 |
T4 | 48 | 16.2 | PSA levels, ng/ml | ||
N Stage | <10 | 69 | 23.3 | ||
N0 | 187 | 63.2 | 10–19.99 | 68 | 23 |
N1 | 109 | 36.8 | 20–20.99 | 39 | 13.2 |
M Stage | 30–30.99 | 20 | 6.7 | ||
M0 | 226 | 76.3 | 40–40.99 | 18 | 6 |
M1 | 70 | 23.7 | 50–50.99 | 22 | 7.4 |
60–99.99 | 39 | 13.2 | |||
>100 | 21 | 7 |